PMV Pharmaceuticals Inc.
Organization details
- Legal name
- PMV Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Princeton
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- PMVP
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001699382
- EIN
- 46-3218129
Board of directors
-
Arnold J. Levine · DirectorSince 2023
-
Carol Giltner Gallagher · DirectorSince 2023
-
Charles M. Baum · DirectorSince 2023
-
David Henry Mack · Director · President and CEOSince 2023
-
Kirsten Flowers · DirectorSince 2023
-
Laurie Stelzer · DirectorSince 2023
-
Matthew Joseph Eckler · DirectorSince 2026
-
Richard A. Heyman · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
51.3%
-
71.5%
Board connections
4 of this board's directors also sit on 7 other boards. 7 are in the same sector.
-
Acrivon Therapeutics Inc. Same sectorvia Charles M. Baum
-
Atara Biotherapeutics Inc. Same sectorvia Carol Giltner Gallagher
-
Enliven Therapeutics Inc. Same sectorvia Richard A. Heyman
-
MBX Biosciences Inc. Same sectorvia Laurie Stelzer
-
Oric Pharmaceuticals Inc. Same sectorvia Richard A. Heyman
-
Sionna Therapeutics Inc. Same sectorvia Laurie Stelzer
-
Spyre Therapeutics Inc. Same sectorvia Laurie Stelzer
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 27, 2025 | David Henry Mack Director, Officer (President and CEO) | Option exercise | +220,643 | $1.37 | $302,281 |
| Oct 23, 2025 | OrbiMed Capital GP V LLC 10% owner | Open-market sale | −1,000,000 | $1.52 | $1,520,000 |
| Sep 10, 2025 | ORBIMED ADVISORS LLC 10% owner | Open-market sale | −500,000 | $1.80 | $900,000 |
| Jul 1, 2025 | Ticktin Robert Officer (General Counsel & COO) | Open-market sale | −23,151 | $1.06 | $24,540 |
| Jul 1, 2025 | Jalota Deepika Officer (Chief Development Officer) | Open-market sale | −33,065 | $1.06 | $35,049 |
| Jul 1, 2025 | Carulli Michael Officer (Chief Financial Officer) | Open-market sale | −28,249 | $1.06 | $29,944 |
| Jul 1, 2025 | David Henry Mack Director, Officer (President and CEO) | Open-market sale | −58,411 | $1.06 | $61,916 |
| Jan 3, 2025 | David Henry Mack Director, Officer (President and CEO) | Option exercise | +17,709 | $0.53 | $9,386 |
| Dec 3, 2024 | David Henry Mack Director, Officer (President and CEO) | Option exercise | +91,750 | $0.53 | $48,628 |
| Sep 11, 2024 | Jalota Deepika Officer (Chief Development Officer) | Open-market sale | −7,218 | $1.50 | $10,827 |
| Sep 11, 2024 | Carulli Michael Officer (Chief Financial Officer) | Open-market sale | −2,891 | $1.50 | $4,337 |
| Jan 18, 2024 | Jalota Deepika Officer (Chief Development Officer) | Grant or award | +95,555 | — | — |
| Jan 18, 2024 | Carulli Michael Officer (Chief Financial Officer) | Grant or award | +82,220 | — | — |
| Jan 18, 2024 | David Henry Mack Director, Officer (President and CEO) | Grant or award | +163,890 | — | — |
| Nov 22, 2023 | OrbiMed Genesis GP LLC 10% owner | Open-market sale | −87,786 | $2.23 | $195,763 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about PMV Pharmaceuticals Inc.
Who is the CEO of PMV Pharmaceuticals Inc.?
David Henry Mack is PMV Pharmaceuticals Inc.'s President and CEO.
How many directors are on PMV Pharmaceuticals Inc.'s board?
PMV Pharmaceuticals Inc.'s board has 8 directors: Arnold J. Levine, Carol Giltner Gallagher, Charles M. Baum, David Henry Mack, Kirsten Flowers, Laurie Stelzer, Matthew Joseph Eckler and Richard A. Heyman.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="pmv-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.